|
References
1. Mokdad, A. CDC Report. Actual Causes of Death in the United
States, 2000. JAMA 2004;293:1238-1245.
2. Rudman D, Feller AG, Nagraj HS Effects of human growth hormone in
men over 60 years old. N Engl J Med. 1990 Jul 5;323(1):1-6.
3. Rudman D, Feller AG, Nagraj HS Effects of human growth hormone in
men over 60 years old. N Engl J Med. 1990 Jul 5;323(1):1-6.
4. Katherine Esposito; Raffaele Marfella et al .Effect of a
Mediterranean-Style Diet on Endothelial Dysfunction and Markers of
Vascular Inflammation in the Metabolic Syndrome: A Randomized Trial;
JAMA. 2004;292:1440-1446.
5. Dietrich M, Jialal I.The effect of weight loss on a stable
biomarker of inflammation, C-reactive protein. Nutr Rev. 2005
Jan;63(1):22-28
6. Antonios M. Xydakis, Christopher C. Case, Peter H. Jones, Ron C.
Hoogeveen, Mine-Yine Liu, E. O’Brian Smith, Kathleen W; Adiponectin,
Inflammation, and the Expression of the Metabolic Syndrome in Obese
Individuals: The Impact of Rapid Weight Loss through Caloric
Restriction. J Clin Endocrinol Metab 2004 89: 2697-2703,2004
7. Cristina Lara-Castro and W. Timothy Garvey; Diet, Insulin
Resistance, and Obesity: Zoning in on Data for Atkins Dieters Living
in South Beach. J Clin Endocrinol Metab 2004 89: 4197-4205
8. Kavey, RE; Americans are living longer, but not necessarily
healthier. American Medical News Vol. 46, #40, Oct. 27, 2003
9. Ito Y ; Serum antioxidants and subsequent mortality rates of all
causes or cancer among rural Japanese inhabitants; Int J Vitam Nutr
Res . 2002 Jul;72(4):237-50.
10. Lasheras C; Independent and interactive association of blood
antioxidants and oxidative damage in elderly people. Free Radic Res,
2002 Aug;36(8):875-82.
11. Hauer K; Improvement in muscular performance and decrease in
tumor necrosis factor level in old age after antioxidant treatment.;
J Mol Med. 2003 Feb;81(2):118-25. Epub 2003 Feb 8.
12. Mendoza-Núñez VM; Total antioxidant levels, gender, and age as
risk factors in the elderly. Mech Ageing Dev. 2001
Jun;122(8):835-47.
13. Katherine Esposito; Raffaele Marfella et al .Effect of a
Mediterranean-Style Diet on Endothelial Dysfunction and Markers of
Vascular Inflammation in the Metabolic Syndrome: A Randomized Trial;
JAMA. 2004;292:1440-1446.
14. Dietrich M, Jialal I.The effect of weight loss on a stable
biomarker of inflammation, C-reactive protein. Nutr Rev. 2005
Jan;63(1):22-28
15. Clearfield M, Downs JR, Lee M, Implications from the Air
Force/Texas Coronary Atherosclerosis Prevention Study for the Adult
Treatment Panel III guidelines. Am J Cardiol. 2005 Dec
15;96(12):1674-80. Epub 2005 Nov 2.
16. Heart Protection Study Collaborative Group Heart Protection
Trial from Great Britain; MRC/BHF Heart Protection Study of
cholesterol lowering with simvastatin in 20 536 high-risk
individuals: a randomised placebocontrolled trial. Lancet
2002;360:7-22
17. Christopher P. Cannon, M.D., Eugene Braunwald, M.D; Intensive
versus Moderate Lipid Lowering with Statins after Acute Coronary
Syndromes, N Engl J Med. 2004;350:1495-1504
18. James A. de Lemos, MD; Michael A Early Intensive vs a Delayed
Conservative Simvastatin Strategy in Patients With Acute Coronary
Syndromes: Phase Z of the A to Z Trial JAMA. 2004;292:1307-1316
19. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC,
Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK; Treating to
New Targets (TNT) Investigators. Intensive lipid lowering with
atorvastatin in patients with stable coronary disease. N Engl J Med.
2005;352:1425-1435
20. Female Urology, Urogynecology, and Voiding Dysfunction; Volume
353:1425, September 29, 2005. Number 13
21. Kaplan ED; Association between homocyst(e)ine levels and risk of
vascular events. Drugs of Today; 2003; 39:175-92.
22. Moat SJ. et al Deficiencies of folic acid, vitamins B6, and B12
are associated with hyperhomocysteinemia; 2003. European Journal of
Clinical Nutrition; 57:483-9.
23. Ueland PM and Refsum H. Plasma homocysteine, a risk factor for
vascular disease: plasma levels in health, disease, and drug
therapy. J Lab Clin Med 1989 Nov;114(5):473-501.
24. Aram V. Chobanian, MD; George L. Bakris, MD; Henry R. Black, MD;
William C. Cushman, MD; Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of
High Blood Pressure. The JNC 7 Report JAMA.
2003;289:(doi:10.1001/jama.289.19.2560).
25. Wolf HK, Tuomilehto J, Kuulasmaa K, Domarkiene S, Blood pressure
levels in the 41 populations of the WHO MONICA Project. J Hum
Hypertens. 1997 Nov;11(11):733-42
26. Hoogwerf BJ, Sprecher DL, Pearce GL, Acevedo M, Frolkis JP,
Foody JM, Cross JA, Pashkow FJ, Robinson K, Vidt DG. Blood glucose
concentrations less-than-or-equal125 mg/dl and coronary heart
disease risk. American Journal of Cardiology 2002 Mar
1;89(5):596-599
27. Stratton IM, Adler AI, Neil HA, Matthews DR,_ Association of
glycaemia with macrovascular and microvascular complications of type
2 diabetes (UKPDS 35): prospective observational study._ BMJ. 2000
Aug 12;321(7258):405-12.
28. Haffner, S.. Lipoprotein disorders associated with type 2
diabetes mellitus and insulin resistance. Am J Cardiol. 2002 Oct
17;90(8A):55i-61i.
29. Shelton, D L. Shape-Up America: Most Patients Don’t See Excess
Weight as Health Danger; American Medical News 1999 Nov 8 .
30. I-Min Lee; Luc Djoussé; Howard D. Sesso; et al. Physical
Activity and Weight Gain Prevention. JAMA. 2010;303(12):1173-1179
31. Middleton LE, Mitnitski A, Fallah N, Kirkland SA, Rockwood K
(2008) Changes in Cognition and Mortality in Relation to Exercise in
Late Life: A Population Based Study. PLoS ONE 3(9): e3124.
32. Mäkinen JI, et al. Sexual Symptoms in Aging Men Indicate Poor
Life Satisfaction and Increased Health Service Consumption. UROLOGY
70: 1194–1199, 2007.
33. Yaffe KL, et al. The Metabolic Syndrome and Development of
Cognitive Impairment among Older Women. Arch Neurol. 2009 March;
66(3): 324–328
34. Reynolds SL, et al. A Tale of Two Countries---the United States
and Japan: Are Differences in Health Due to Differences in
Overweight? J Epidemiol 2008; 18(6) 280-290.
35.
Stevens WD, et al. A Neural Mechanism Underlying Memory
Failure in Older Adults.
The Journal of Neuroscience, November 26, 2008 • 28(48):12820
–12824
36. Gallucci M, et al. Neurodegenerative Diseases. Radiol Clin N Am
46 (2008) 799–817
37. Drachman DA. Aging Of The Brain, Entropy, And Alzheimer Disease.
Neurology 2006;67:1340–1352
38. Peppa M, Uribarri J, Vlassara H. Aging and glycoxidant stress.
Hormones 2008, 7(2):123-132
39. Semba RD, et al. Oxidative Stress and Severe Walking Disability
among Older Women. The American Journal of Medicine (2007) 120,
1084-1089
40.
Raymann RJ, Van Someren EJ.
Diminished Capability to Recognize the Optimal Temperature for Sleep
Initiation May Contribute to Poor Sleep in Elderly People. SLEEP
2008;31(9):1301-1309.
41. Wouts L. Cardiac Disease, Depressive Symptoms, and
Incident Stroke in an Elderly Population. Arch Gen Psychiatry.
2008;65(5):596-602.
42. Morley JE. Diabetes and Aging: Epidemiologic Overview. Clin
Geriatr Med 24 (2008) 395–405.
43. Sattler
FR, et al. Testosterone and Growth Hormone Improve Body Composition
and Muscle Performance in Older Men.
J
Clin Endocrinol Metab 94:1991–2001, 2009
45. Danaei G,
Ding EL, Mozaffarian D, Taylor B, Rehm J, et al. (2009) The
Preventable Causes of Death in the United States: Comparative Risk
Assessment of Dietary, Lifestyle, and Metabolic Risk Factors. PLoS
Med 6(4): e1000058.
|
